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Abstract
Background: Human and animal health is constantly under threat by emerging pathogens that
have recently acquired genetic determinants that enhance their survival, transmissibility and
virulence. We describe the construction and development of an Active Surveillance of Pathogens
(ASP) oligonucleotide microarray, designed to 'actively survey' the genome of a given bacterial
pathogen for virulence-associated genes.
Results: The microarray consists of 4958 reporters from 151 bacterial species and include genes
for the identification of individual bacterial species as well as mobile genetic elements (transposons,
plasmid and phage), virulence genes and antibiotic resistance genes. The ASP microarray was
validated with nineteen bacterial pathogens species, including Francisella tularensis,  Clostridium
difficile,  Staphylococcus aureus,  Enterococcus faecium and  Stenotrophomonas maltophilia. The ASP
microarray identified these bacteria, and provided information on potential antibiotic resistance (eg
sufamethoxazole resistance and sulfonamide resistance) and virulence determinants including genes
likely to be acquired by horizontal gene transfer (e.g. an alpha-haemolysin).
Conclusion: The ASP microarray has potential in the clinic as a diagnostic tool, as a research tool
for both known and emerging pathogens, and as an early warning system for pathogenic bacteria
that have been recently modified either naturally or deliberately.
Background
Despite advances in the treatment of infectious disease,
pathogenic bacteria represent one of the most important
threats to health worldwide. Many infectious disease
agents have never been controlled or have re-emerged as
global pathogens, while others pose a new threat.
Recently emerged pathogens of heightened virulence
include Vibrio cholerae O139 strains [1,2], Escherichia coli
0157 [3,4], Salmonella enteritidis phage type-4 [5] and the
multidrug resistant phage type-DT104, all of which have
emerged over the last decade as a global health problem
in both human and animal disease [6]. There is now clear
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evidence that these pathogens have become more virulent
by acquiring genome segments through lateral gene trans-
fer that result in gain-of-function traits [7]. This is dramat-
ically illustrated by the transfer of antimicrobial resistance
determinant among pathogenic (and non-pathogenic)
bacteria such as meticillin resistant Staphylococcus aureus
(MRSA) and multidrug resistant enterococci. The identifi-
cation of newly acquired potentially harmful genetic ele-
ments and antibiotic resistances could influence clinical
practice and policy, resulting in more effective treatment.
Additionally, this identification of new traits could prove
vital in the identification of bioterrorism threats, where
the deliberate release of highly virulent pathogens is a
major concern, particularly if the genome of the infectious
agent has been modified with virulence determinants for
nefarious purposes.
In the last few years, research in microbial pathogenesis
and molecular epidemiology has changed fundamentally,
from a piecemeal approach of characterising individual
determinants or point mutations to a global analysis of
pathogen genomes, fuelled by the ability to determine the
complete genome sequence of microorganisms. This ena-
bled the development of high-throughput nucleic acid
hybridisation technologies including macro- and microar-
rays involving amplified gene fragments and oligonucle-
otide arrays (e.g.  Affymetrix GeneChips). Microarrays
have the capacity to rapidly monitor the genome content
of bacterial strains and identify horizontal gene transfer
elements, using thousands of reporter elements in a given
experiment. Horizontal gene transfer is a major evolution-
ary mechanism for bacteria [8,9], methods that can dem-
onstrate gene acquisition (and loss) are crucial in
identifying emerging pathogens, and could act as an early
warning of the emergence of a potentially more virulent
strain. At present microarray technology is limited to
mainly single species microarrays. Yet the continued
expansion of available genome sequence data and our
increased understanding of the genetic basis of microbial
virulence, this has presented a unique opportunity to
monitor the genome content of microorganisms and the
emergence of more virulent pathogens. With this in mind
we report the development and application of an Active
Surveillance of Pathogens (ASP) microarray for monitor-
ing gene flux in pathogens, antimicrobial resistance and
virulence profile, along with potentially identifying gene
acquisitions and new outbreak strains. The ASP array is
unique in that it represents known virulence determi-
nants, antibiotic resistance genes and pathogenicity traits
from 151 bacteria species, covering a broad range of spe-
cies and genera on a single microarray. This provides an
unparalleled opportunity to study gene flux and identify
novel traits. The ASP microarray was validated with 19
bacterial species, ranging from those who's fully curated
genome sequences were available, to those that were
unsequenced, with little or no background information;
including a blind control of a sample from unknown ori-
gins. The ASP array identified both known and unknown
samples, including; Francisella tularensis, Clostridium diffi-
cile, Staphylococcus aureus, Vancomycin resistant Enterococ-
cus faecium (VRE) and Stenotrophomonas maltophilia and
provided information on drug resistance and the presence
of potential virulence determinants.
Methods
Selection of oligonucleotide gene reporters for microarray
Prior to the design of the oligonucleotides, a database of
potential bacterial coding sequences (CDS) was estab-
lished using published completed genome sequences;
thus ensuring consistency in gene location and identity. A
Perl script was used to extract CDS sequences from the
sequence reference database (RefSeq) http://www.ncbi.nl
m.nih.gov/projects/RefSeq/, which consists of curated
completed and published genomes. Reporters for the ASP
microarray were designed from CDS categorised by TIGR
as either 'cell adhesion', 'detoxification', 'toxin production
& resistance' or 'pathogenicity' http://cmr.tigr.org/tigr-
scripts/CMR/shared/RoleList.cgi or TIGR Annotation
search http://cmr.tigr.org/tigr-scripts/CMR/shared/Make
FrontPages.cgi?page=searches&crumbs=searches. Along-
side these, additional reporters were designed based on
ribosomal protein subunit genes, these were selected for
their species, genus and family specificity. 16S/23S genes
were not used due to their high degree of conservation.
The oligonucleotide reporters were designed using
OligoArray2.1 software [10]. Irrespective of GC content of
the target genome the following parameters were set; GC
content 40–60%, Tm 85–90°C and runs of five homolo-
gous bases were prohibited. If OligoArray2.1 failed to
design oligonucleotides for the majority of CDS, relaxed
parameters were applied as follows; maximum GC-con-
tent was increased to 68% and maximum Tm increased to
94°C for high GC-content organisms. For low GC-content
organisms the minimum GC-content was lowered to 35%
and the minimum Tm decreased to 83°C. Oligonucle-
otides were checked by BLASTN [11] using default settings
but with a seed word length of seven (due to short oligo-
nucleotide sequence length) and an e-value cut-off of
0.0001, against all CDS from all available species within a
genera. If any oligonucleotides, had a match with a bit
score of greater than 72 (approximately >45/50 bp match)
to CDS other than that on which it was designed, the oli-
gonucleotides for these CDS were considered redundant
and thus removed i.e. one oligonucleotide will produce
signal from homologous CDS, this accounts for dupli-
cated genes or gene families. Subsequently a self-self
BLAST for all selected oligonucleotides was performed to
check for redundancy within the oligonucleotides, again
any two oligonucleotides which shared greater than 45/50BMC Microbiology 2008, 8:177 http://www.biomedcentral.com/1471-2180/8/177
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base pair identity were deemed to be a duplication and
one was removed from the potential oligonucleotide list.
This iterative approach allows for expansion of only novel
reporter elements with the addition of each newly pub-
lished genome sequence. The current ASP microarray
(v5.3) consists of 4958 oligonucleotide reporters (addi-
tional file 1) designed from 99 bacterial genera (151 spe-
cies, 205 genomes, plus at least 100 mobile genetic
elements (MGE) additional file 3).
Construction of ASP microarrays
All oligonucleotides were synthesised by MWG Biotech
(Ebersberg, Germany). Oligonucleotides were suspended
in 50% DMSO at a final concentration of 50 μM. Microar-
rays were constructed as described previously [12] by
robotic spotting of oligonucleotides in duplicate on Ultra-
Gaps amino-silane coated glass slides (Corning, USA).
The microarrays were post-print processed according to
the slide manufacturer's instructions.
DNA extractions
Where strains were provided, they were grown in the rec-
ommended media, at the recommended temperature.
DNA isolations was performed using either the wizard
DNA extraction kit (Promega) or the Puregene DNA isola-
tions kit (Gentra Systems) in accordance with the manu-
facturer's protocols for extraction of either Gram positive
or Gram negative bacteria as appropriate. For C. difficile,
the Puregene Gram positive extraction method was uti-
lised with the addition of 175 μg lysozyme to aid cell lysis,
followed by snap freeze using a dry ice and ethanol bath.
Samples were then heated to 80°C for 15 min, and the
manufacturer's protocol was then resumed.
Hybridisation conditions & data acquisition
Test samples were labelled and hybridised as described
previously [13] using 3–6 μg DNA with a formamide
based hybridisation buffer solution (30% formamide,
3.75× Denhart's solution, 3.75 × SSC, 0.75 mM Na4P2O7,
37.5 mM Tris pH 7.4, 0.075% SDS, 0.056 mg/ml used
tRNA, modified from [14]) in a final volume of 48 μl at
50°C for 16–20 hours. The microarrays were washed as
described previously but with the initial wash at 50°C
[13]. The microarrays were scanned using a 418 microar-
ray Scanner (Affymetrix, USA) and intensity fluorescence
data acquired using ImaGene 5.5 (BioDiscovery, USA).
After scanning, a commercial SpotCheck kit (Invitrogen)
consisting of Cy3 labelled random 9-mers was used to
hybridize to the microarray, which binds to all the report-
ers on the microarray. The microarray was then washed
and scanned as before but without preheating the initial
wash. This step is essential due to the small number of
reporters, which hybridise with specific samples and
serves as a valuable control to confirm microarray reporter
presence on the microarray.
Data analysis
Initially positive reporter identification was attempted
using the proprietary algorithms of ImaGene and Blue-
Fuse software however these lacked the specificity and
defined cut-offs required. The method described by Cas-
sone et al. [15] was used to identify positive reporters.
Each reporter was present on the ASP microarray in dupli-
cate, for each replicate the median of the background sig-
nal was deducted from the reporter spot median
fluorescence using Excel to give hybridisation signal (fig-
ure 1, 2, 3). The mean (m) and standard deviation (sd) of
replicate hybridisation signals was calculated. Addition-
ally the background corrected mean (M) and standard
deviation (SD) for the whole microarray was calculated
(figure 1, 2, 3). The data analysis methodology utilised
two main calculations to determine whether a particular
reporter was present in any given strain. Firstly, for true
positives the signal should be consistent between micro-
array replicates, therefore if the signal mean was greater
than the standard deviation of the spot intensities for a
particular reporter (m>sd) this was given a pass, whereas
sd>m was given a fail. Secondly, most of the reporters on
the microarray do not produce signal, therefore a true pos-
itive reporter must be significantly brighter than the back-
ground reporters, therefore if the reporter signal mean
(m) was greater than the microarray mean M plus SD
(m>M+SD) this was given a pass and m<M+SD a fail (fig-
ure 1, 2, 3). Reporters were considered present if given a
pass for both tests. The resultant gene lists were then
entered into GeneSpring. Subsequently in GeneSpring the
list of positive reporters was compared to a database of
lists consisting of: BLAST predictions, results from previ-
ous hybridisations and lists of all the oligonucleotides
from each species present in the design database. This
identified similarities between gene lists and hybridisa-
tion results. For each reporter list, the hypergeometric
probability (p-value) was calculated. This probability
indicates the level of similarity between gene lists,
whereby the p-value was the probability that two gene
lists (n & m) share a subset of genes (k) if randomly
selected from all ASP microarray genes (u). A low p-value
indicates that the lists were not similar by chance.
The test gene list was then added to the database. The con-
tinual addition to this database enables comparison to be
made between the database and future samples to predict
gene content and some degree of identification, for both
known and unknown samples.
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Vectorette PCR
Vectorette PCR [16] enables the amplification of specific
DNA fragments where only one primer, in this case a 50
mer reporter, is known and was employed to validate the
hybridisations. Genomic DNA was digested with either,
AluI (Promega), EcoRV (Promega), PvuII (Promega) or
RsaI (NEB) and heat-inactivated where appropriate, in
accordance with the manufacturer's protocol. The vec-
torette bubble unit was prepared by annealing the oligo-
nucleotides LDF1F and LDF1R (additional file 2). The
vectorette unit was then ligated to the individual digested
DNA, using T4 ligase (Promega) in accordance with the
manufacturer's protocol. Nested 30–32 mer oligonucle-
otides were designed from within the 50 mer microarray
reporter (additional file 2), along with nested primers
complimentary to the vectorette bubble (additional file
2). Primary PCR reactions were performed using the vec-
torette internal primer LDF2, and the gene specific primer
(5 μM of each primer). The PCR reactions were performed
using 2.5 units of Taq polymerase (Promega) in accord-
ance with the manufacturer's protocol, 35 cycles of 92°C
30 sec, 38°C 1 min, 72°C 1 min and a final cycle 72°C 10
min. The secondary PCR was performed using the primary
PCR reaction, with nested gene specific primer and nested
vectorette primer. A total of 40 cycles of 92°C 30 sec,
55°C 1 min and 72°C 1 min with a final cycle 72°C 10
min. The secondary PCR products were separated on an
agarose gel and gel extracted using the QiaQuick gel
extraction protocol (Qiagen) in accordance with the man-
ufacturer's protocol. The purified PCR products were then
cloned into pGEM (Promega) in accordance with the
manufacturer's protocol and sequenced, using M13 for-
ward and reverse primers (additional file 2). The resultant
sequences were run through BLAST to identify the cloned
genes.
Results
Choice of gene reporters for the ASP array
The ASP microarray was designed to function as a single
Cy dye microarray, giving present/absent information
about genes based on whether a reporter fluoresces or not.
This is not a quantitative comparative assay, therefore two
samples can be analysed independently on each microar-
ray simultaneously by labelling one sample with Cy3 and
Distribution of ASP reporter intensities and positive signal selection cut-offs for F. tularensis SCHU S4 Figure 1
Distribution of ASP reporter intensities and positive signal selection cut-offs for F. tularensis SCHU S4. Pink dots 
= Individual ASP reporters (mean) signal, yellow line = mean fluorescence of all ASP microarray reporters, light blue line = one 
standard deviation (SD) of all ASP microarray reporters, mauve line = mean + SD, reporters with signal greater than mean+SD 
were selected as positive.
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the other with Cy5. The concept microarray (ASPv1) was
performed to compare oligonucleotides and PCR product
microarrays using important pathogenic bacteria includ-
ing Mycobacterium tuberculosis, S. aureus and Y. pestis (data
not shown) and oligonucleotides were selected for use as
reporters.
Hybridisation of DNA from bacterial pathogens
Validation was carried out using a selection of 19 bacteria
(table 1) which fell into three "Rumsfeld" categories;
'known knowns' (KK) – consisting of fully sequenced and
curated genome sequences, which enable BLAST predic-
tions to be performed, 'known unknowns' (KU) – bacteria
where partial or no sequence information is available, but
for which limited information is available regarding spe-
cies and drug resistances, and lastly 'unknown unknowns'
(UU) – unsequenced bacteria with no prior information
regarding species or drug resistance profile.
"Known knowns"
In order to validate the ASP microarray design and the
bioinformatic analysis of data, a selection of sequenced
isolates were used (table 1). The three examples presented
in this study include F. tularensis SCHU S4, S. aureus COL
and C. difficile 630. BLAST revealed that out of all the 4958
reporters on the microarray, F. tularensis SCHU S4 was
predicted to hybridize to 27 reporters, S. aureus COL 107
(104 chromosomal and 3 plasmid) reporters, whereas C.
difficile was predicted to hybridize to only two reporters.
Hybridisation results were compared to BLAST predic-
tions.
Hybridisation with F. tularensis SCHU S4 identified 29
positive reporters (figure 1), consisting of 27 predicted by
BLAST. The two additional reporters were Cg34500228
and Cp39102563, however BLAST analysis of these
reporters against the F. tularensis SHCU S4 genomes did
not produce a match of greater than 22/26 bp, which was
not predicted to be sufficient for hybridisation.
Distribution of ASP reporter intensities and positive signal selection cut-offs for C. difficile 630 Figure 2
Distribution of ASP reporter intensities and positive signal selection cut-offs for C. difficile 630. Pink dots = Indi-
vidual ASP reporters (mean) signal, yellow line = mean fluorescence of all ASP microarray reporters, light blue line = one 
standard deviation (SD) of all ASP microarray reporters, mauve line = mean + SD, reporters with signal greater than mean+SD 
were selected as positive.
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Hybridisation with S. aureus COL DNA confirmed 101 of
107 BLAST predicted reporters in at least one of three
hybridisations. Five predicted reporters produced weak
signal just below the signal intensity cut-off and one pro-
duced negligible signal. Five additional reporters present
by hybridisation were not predicted by BLAST. Four genes
predicted to be present in S. aureus COL by hybridisation
and/or BLAST were chosen for analysis by vectorette PCR
to determine if the reporters were cross-hybridising to
non-specific DNA. Haemolysin (Sa29510762) was used
as a proof of principle control, it was positive in both
BLAST prediction and hybridisation experiments. Exo-
toxin 3 (Sa29510468) was predicted by BLAST to be pos-
itive, yet the hybridisation failed for this reporter and
finally two reporters positive by hybridisation but not pre-
dicted by BLAST; bleomycin resistance (Sa29520032) and
chloramphenicol resistance (Cv50850700). The vec-
torette PCR amplified a band for the haemolysin, which
was sequenced and proven to be the haemolysin gene
(SACOL0762) (table 2). The exotoxin 3 was also con-
firmed as exotoxin 3 by vectorette PCR (table 2), suggest-
ing the hybridisation conditions used for the arrays were
not optimal for this specific reporter. Interestingly, the
vectorette PCR for bleomycin and chloramphenicol resist-
ance did not produce products with any of the four differ-
ent S. aureus COL vectorette libraries (table 2), suggesting
that the hybridisations on the microarray may have been
due to miss-priming, or binding to non-specific DNA.
C. difficile strain 630 was used to test the microarray, there
were no reporters specifically designed from C. difficile
630, as only the pre-release genome sequence was availa-
ble at the time of design and was therefore not included.
C. difficile 630 CDS information was obtained from the
pre-release genome using Artemis http://
www.sanger.ac.uk/Software/Artemis/ and BLAST analysis
against the ASPv5.3 oligonucleotides was performed. Two
reporters on the microarray (M50000021 and
Sa41160923) had 100% identity to two genes within C.
difficile 630, a duplicated erythromycin resistance trans-
ferase (Cd630-2007 & -2010) and a tetracycline resistance
gene (Cd630-0508). Hybridisations with C. difficile 630
genomic DNA revealed three positive reporters, the two
mobile genetic elements as predicted, and the type III
Distribution of ASP reporter intensities and positive signal selection cut-offs for S. aureus COL Figure 3
Distribution of ASP reporter intensities and positive signal selection cut-offs for S. aureus COL. Pink dots = Indi-
vidual ASP reporters (mean) signal, yellow line = mean fluorescence of all ASP microarray reporters, light blue line = one 
standard deviation (SD) of all ASP microarray reporters, mauve line = mean + SD, reporters with signal greater than mean+SD 
were selected as positive.
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Table 1: Bacterial species tested on the ASPv5.3 to date
Bacterial 
species
Genome 
available?1
Rumsfeld 
Category
Ribosomal 
predictions7
No. strains tested 
on ASP microarray
Correct ID 
p-value2
Best 
mis-ID3
mis- 
ID3
p-value
v1 v2 v3 v4.3 v5.3
Acinetobacter baumannii 
(γ-proteobacteria)
No UU no ribosomals 1 1 1 N/A (0+12)4 None5 -
Bacillus anthracis 
(firmicutes)
Yes KK n/a 1 1 3 3 4.43e-170 (0+122) B. cereus 1.31e-133
Burkholderia mallei (β-
proteobacteria)
Yes KK n/a 3 3 1.55e-179 (5+136) B. pseudomallei 1.34e-163
Burkholderia pseudomallei 
(β-proteobacteria)
Yes KK n/a 3 3 6.61e-171 (2+159) B. mallei 3.43e-110
Clostridium difficile 
(firmicutes)
Yes KK n/a 1 1 9 12 4 1.11e-4 (0+3) None -
Clostridium sordellii 
(firmicutes)
No UU no ribosomals 1 1 N/A (0+2) None -
Clostridium tetani 
(firmicutes)
No UU no ribosomals 1 1 N/A (0+1) None -
Coxiella burnetii (γ-
proteobacteria)
Yes KK n/a 2 3 3.32e-19 (0+11) None -
Enterobacter sakazakii 
(enterobacteriaeae)
No UU γ-proteobacteria (10/14 
enterobacteriaceae)
14 11 14 N/A (10+13) E. coli 1.35e-11
Enterobacter cloacae 
(enterobacteriaeae)
No UU γ-proteobacteria (10/11 
enterobacteriaceae)
11 1 N / A  ( 3 + 1 9 ) E. coli 3.47e-7
Entrococcus faecium 
(firmicutes)
No UU Firmicutes 2 2 2 N/A (1+11) S. aureus 7.77e-4B
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Escherichia coli (γ-
proteobacteria)
Yes KU n/a 1 1 1 1 8.82e-9 (8+23) S. flexneri 1.35e-4
Francisella tularensis (γ-
proteobacteria)
Yes KK n/a 3 3 7.33e-65 (3+24) None -
Klebsiella pneumoniae (γ-
proteobacteria)
No UU n/a 1 1 1 N/A (0+8) E. coli 3.19e-4
Legionella pneumophilia 
(γ-proteobacteria)
Yes KK n/a 3 3 7.08e-102 (0+58) None -
Staphylococcus aureus 
(firmicutes)
Yes KK/KU n/a 2 1 1 3 8.18e-168 (KK) (4+98) 
5.87e-129 (KU) (10+102)
None -
Stenotrophomonas 
maltophilia (γ-
proteobacteria)
No KU6 proteobacteria (γ- or β-) 1 1 1 N/A6 (1+6) None -
Yersinia pestis (γ-
proteobacteria)
Yes KK n/a 3 2 2 1.35e-219 (11+188) Y. pseudoTB 5.32e-202
Yersinia 
pseudotuberculosis (γ-
proteobacteria)
Yes KK n/a 3 3 8.65e-199 (10+129) Y. pestis 3.44e-188
1 = Indicates availability of at least one sequenced strain at time of analysis. 2 = example p-value for correct prediction (on ASPv5.3), 3 = example of best incorrect prediction and p-value (on 
ASPv5.3), 4 = number of positive reporters from example hybridisation (ribosomals + 'virulence' genes), reporters from these genus/species underrepresented on ASPv5.3 due to lack of 
completed genome sequences however positive genes give information of bacteria (e.g. antibiotic resistance) and any positive ribosomal genes can be used to predict to the level of family/genus, 
5 = None indicates no significant match with any BLAST predictions within current database, 6 = S. maltophilia sequence not available at time of analysis, 7 = identification of UU's using ribosomal 
genes (n/a = not appropriate if species can be elucidated), if present, based on the number of genera which the ribosome is present in at least 1 species (number of predicted genera including 
duplicates).
Table 1: Bacterial species tested on the ASPv5.3 to date (Continued)BMC Microbiology 2008, 8:177 http://www.biomedcentral.com/1471-2180/8/177
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secretion protein HrpT (Ps45781390) designed from
Pseudomonas syringae DC3000. By BLAST, Ps45781390
had only a partial match to the C. difficile 630 genome.
The presence of the two predicted genes in C. difficile 630
was confirmed using vectorette PCR (methods section)
using the vectorette libraries derived from C. difficile 630.
"Known unknowns"
Eight clinical isolates were obtained from Kings College
Hospital, London and had been identified to species level
and tested for antimicrobial susceptibility using conven-
tional methods. However, these pathogens had not been
sequenced and therefore BLAST analysis could not be per-
formed, but hybridisations results could be compared to
BLAST predictions from other sequenced strains. These
pathogens were used to test the ability of the ASP micro-
array to identify, distinguish and predict gene content.
Two bacterial pathogens, S. aureus and  E. faecium, are
described here as examples.
The S. aureus strain tested on ASPv5.3 was a Panton-Val-
entine leukocidin (PVL) positive Community Acquired
(CA)-MRSA with known antimicrobial resistances (ampi-
cillinR, meticillinR and penicillinR). Hybridisations identi-
fied 112 positive reporters on the ASP microarray which
most closely resembles S. aureus strain MRSA252 (hyper-
geometric probability p-value of 5.87e-129) (table 1). The
positive ASP reporters included four meticillin resistance-
associated genes and a β-lactamase precursor, which cor-
roborates the known antimicrobial resistance phenotype.
Additionally, putative resistances to bicyclomycin, bleo-
mycin, fluoroquinolones, chloramphenicol, sufamethox-
azole, and sulphonamide were identified. Although
sensitive to antibacterial glycopeptides, this isolate carries
two teicoplanin resistance-associated genes, BLAST analy-
sis of these ASP reporters sequences identified matches
with 100% identity in fourteen S. aureus complete
genomes. Interestingly, both genes required for PVL and
an additional leukocidin were also detected, which cor-
roborates the known toxin phenotype. Additionally, a fur-
ther 13 exotoxins were identified; an exfoliative toxin A,
an α-haemolysin, γ-haemolysin (components A, B & C), a
putative haemolysin, a putative vacuolating cytotoxin and
a β-haemolysin. Two S. aureus pathogenicity islands were
partially identified, one from the bovine S. aureus RF22
(5/7 reporters) and the other from S. aureus COL (3/9
reporters). Of interest were 12 non-S. aureus reporters, six
of which were designed from plasmids (table 3). This
indicates that the ASP microarray has identified genes that
are potentially novel to S. aureus, which may have been
acquired by horizontal gene transfer (table 3).
The two vancomycin-resistant E. faecium (VRE) isolates,
distinguishable by tetracyclineR  (KCH1) and linezoidR
(KCH2), were both resistant to ampicillin, erythromycin,
gentamicin, penicillin, rifampicin and trimethoprim.
DNA from both isolates were tested in duplicate on the
ASP microarray. ASPv5.3 did not contain any specific E.
faecium reporters, however the microarray did contain 40
reporters from the related species E. faecalis (strain V583).
As no E. faecium strains have been sequenced it was not
possible to predict which, if any, E. faecalis V583 reporters
Table 2: Summary of BLAST prediction, hybridisation data and vectorette PCR for putative S. aureus COL genes
Gene Name/phenotype Gene ID BLAST/hyb Vectorette product Top Hit Size
Haemolysin SACOL0762 Yes/Yes Yes SACOL0762 126/126
Exotoxin 3 SACOL0468 Yes/No Yes SACOL0468 362/362
Bleomycin resistance SAR0032 No/Yes No n/a n/a
Chloramphenicol resistance CV0700 No/Yes No n/a n/a
Table 3: Potential horizontally acquired genes predicted by ASP microarray in a clinical CA-MRSA isolate
Reporter Annotation Information source Location
Ba693320065 Type IV secretion system protein VirB5 Brucella abortus Chromosome
Bq595505520 Alpha-hemolysin Bartonella quintana Chromosome
Bq595505860 Invasion associated locus B (IalB) protein family Bartonella quintana Chromosome
Cv50850766 Probable multidrug resistance protein Chromobacterium violaceum Chromosome
M49450015 Ethidium bromide resistance protein QacEdelta1 Corynebacterium glutamicum Plasmid
M49450016 Sufamethoxazole resistance protein SulI Corynebacterium glutamicum Plasmid
M49730008 Sulfonamide-resistant dihydropteroate synthase Uncultured eubacterium Plasmid
Nm31162146 Neisseria-specific antigen protein, TspA Neisseria meningitides Chromosome
pFCM1Amp Ampicillin resistance Cloning vector (Tn7 based) Plasmid
pRSB10115Su Dihydropteroate synthetase type 1 confers sulfonamide resistance Uncultured eubacterium Plasmid
pRSB10116Qac Quaternary ammonium resistance Uncultured eubacterium PlasmidBMC Microbiology 2008, 8:177 http://www.biomedcentral.com/1471-2180/8/177
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would hybridise. Hybridisations on the ASP microarray
identified eight genes that were present in both strains of
VRE, including five vancomycin resistance related genes,
four of which matched the vancomycinR operon genes
found on the S. aureus plasmid pLW043. The other four
hybridisation positives were to an erythromycin resistance
transferase and two genes from the related organism E.
faecalis; an adhesion lipoprotein and a S14 ribosomal pro-
tein. The ribosomal reporter S14 was used for identifica-
tion of the bacteria, however the discriminatory power of
this particular ribosomal reporter was limited to the phy-
lum firmicutes due to sequence homology from bacteria
within two different orders (Bacillales and Lactobacilla-
les). The reporter list for VRE KCH1 contained the tetracy-
cline reporter, which was absent in the reporter list for the
second test sample VRE KCH2; thus ASP data corresponds
to the known sensitivities of these bacteria as indicated
above. BLAST analysis of the tetracycline reporter pro-
duced a 100% match to a E. faecium tetracycline resistance
gene (accession number AY081910). VRE KCH1 ASP
hybridisation results also identified potential resistance
conferred by streptothricin acetyltransferase and strepto-
mycin aminoglycoside 6-adenyltransferase. However, sus-
ceptibility to these agents is not routinely determined. To
confirm this in-vitro, susceptibility testing was performed
using streptomycin on both VRE, each isolate exhibited an
MIC of >128 mg/L.
The reporter lists for both of the VRE strains have been
incorporated into the gene lists in GeneSpring, which
importantly, this will expedite the identification of future
VRE isolates.
"Unknown unknowns"
Stenotrophomonas maltophilia, a member of the γ-proteo-
bacteria, is a pathogen found in immunocompromised
patients and is naturally resistant to many broad-spec-
trum antimicrobials, making it often difficult to treat.
Until the very recent publication of the S. maltophilia
K279a genome sequence in 2008 [17] little genetic infor-
mation was available for this organism. A clinical isolate
of S. maltophilia was obtained from the Kings College Hos-
pital with no information on the antimicrobial suscepti-
bility profile. The reporter list identified it as a β- or γ-
proteobacteria species by the ribosomal reporter
(Bp63503218). Six further reporters were linked to anti-
microbial resistance and detoxification (table 4), which
may give an insight into the drug resistances of this isolate
of S. maltophilia. For example reporter (Ps70052483) was
annotated as conferring acriflavin resistance and S. mal-
tophilia ULA-511 has been demonstrated to be acriflavin
resistant [MIC 256 μg/ml] [18]. The subsequent release of
the S. maltophilia K279a genome, allowed a BLAST analy-
sis to be performed, which confirmed a match of between
43/50 bp to 47/50 bp for five out of seven reporters (table
4). The remaining two reporters were specific to this clin-
ical isolate.
The ASP microarray in this case was able to identify the
bacterium to either a β- or γ-proteobacteria class, and
importantly provided some insight into the potential anti-
biotic resistance profile of this understudied organism.
This positive reporter list was added into the hybridisa-
tions database to expedite the distinction of S. maltophilia
from other bacteria.
Classification of unknown bacteria using ribosomal reporters
Ribosomal reporters were added to the ASP microarray to
aid identification of test organisms, however 16S and 23S
were not selected due to their high level of conservation
among species. The discriminatory power of the ribos-
omal reporters was assessed in Table 1. For example, a test
organism identified eleven ribosomal genes (table 5) on
the ASP microarray, these ribosomal reporters were then
used in a BLAST analysis, which identified 11 bacterial
genera, all predicted by BLAST to contain at least one of
the ribosomal reporters (table 5). All of these 11 bacterial
genera fell within the γ-proteobacteria. Further analysis
revealed that six of the genera are all members of the
Enterobacteriaceae family, however, more importantly all
eleven reporters are only present in the Yersiniae (table 5).
Furthermore, one reporter (Yp58100797) appears to be
specific to the Yersiniae (table 5), therefore using only the
ribosomal reporters only, it suggests that the test organism
was a member of the γ-proteobacteria and most likely of
the genus Yersinia.
Table 4: Positive ASP microarray reporters from a clinical isolate of S. maltophilia
Reporter Annotation BLAST match with S. maltophilia K279a
As65131772 Bacterial type II secretion system protein E 43/50
Bp63503218 30S ribosomal protein S12 45/50
Bt76501375 Heavy metal efflux pump CzcA 43/50
Pf41290909 Superoxide dismutase, Mn 47/50
Ps70052483 Acriflavin resistance protein 45/50
Se69051442 Secretion system apparatus SsaT no hit
Tt38691142 ABC-type multidrug transport system, permease component no hit
Five reporters predicted by ASP were also present in the S. maltophilia K279a sequence strain but two genes were specific to the clinical isolateBMC Microbiology 2008, 8:177 http://www.biomedcentral.com/1471-2180/8/177
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Discussion
The ASP array has validated over 823 gene sequences as
suitable reporters from 19 pathogens. The reporters
include both chromosomally located and plasmid
encoded antimicrobial resistance cassettes, pathogenicity
islands, secretion systems, effectors, toxins, drug export
and detoxification systems designed from 99 different
genera, 151 species, 205 genomes (additional file 3). In
addition, accompanying reporters were designed from
ribosomal proteins to aid in genera differentiation. This
provides the opportunity to test an unlimited number of
bacteria species to determine the content of their potential
virulence determinants. One limitation of DNA hybridisa-
tions is that the presence of a gene reporter does not dem-
onstrate that the gene is functional. For example a
pathogen may carry a drug resistance gene or part of a
resistance cassette/operon but may be currently sensitive
to that antibiotic, however the presence of a non-
expressed resistance gene does indicate that there is a
higher potential for resistance to be developed under
exposure to the right antibiotics, which could influence
choice of treatment antibiotic.
The ASPv5.3 microarray was tested and validated on a
range of bacterial pathogens, from those with available
genome sequences (e.g. F. tularensis SCHU S4, S. aureus
COL and C. difficile 630) to those that are clinically impor-
tant, but have limited information regarding antimicro-
bial resistance profile or genetic information, such as S.
maltophilia. The S. aureus COL validation of the ASP
microarray demonstrated that accurate prediction of pos-
itive reporters on the ASP microarray was achievable and
that this data, confirmed by vectorette PCR, could be used
successfully to identify bacteria with a very high level of
certainty. The majority of predicted reporters produced
positive signals, including plasmid-based genes, with only
a few absent. As many antibiotic resistance genes are plas-
mid mediated, it is important to ensure extraction of both
chromosomal and plasmid DNA for testing. In the case of
S. aureus COL 3 BLAST predicted genes were located on
the S. aureus COL plasmid pT181, all of which were posi-
tive in a least one hybridisation, suggesting that the 'chro-
mosomal' preparation also extracted plasmid DNA,
however the limitation is that the cannot distinguish chro-
mosomal versus plasmid encoded. As predicted there
were a few differences between observed (hybridisations)
and predicted (BLAST) results, which did not adversely
effect the identification of the bacteria. These differences
can be attributed to hybridisations or bioinformatics
errors. For such a large array, including reporters for a
wide range of bacteria it was predicted that some of the
reporters would fail, either in design, synthesis, microar-
ray production or under the hybridisation conditions for
the oligonucleotides. There are a number of ways of
addressing the issue, however all have their limitations,
one could increase stringency by increasing the value of
the minimum positive signal cut-off to result in fewer false
positives, yet this would produce more false negatives.
The reducibility of the replicate spots is a critical factor for
being defined as positive, greater accuracy could be
achieved with either more replicates or multiple reporters
per gene. However, duplicate reporters per gene would
increase the cost of oligonucleotides, yielding little addi-
tional data. Both methods would greatly increase (up to
double) the size of the microarray and physical space on
the glass slide is finite. Improvements in printing density
and microarray fabrication can currently manufacture up
to 1,000,000 reporters directly onto a slide for a fixed cost,
which would enable a greater number of reporters, and,
therefore the physical size of the microarray, but practi-
cally this may result in lower signal as the labelled DNA is
diluted and dispersed over a greater area. Sensitivity, sig-
Table 5: Ribosomal reporters identified in an unknown isolate (Y. pseudotuberculosis) and their predicted conservation within the 
prokaryotes
Reporter Enterobacter Erwinia Escherichia Haemophilus Pasteurella Photorhabdus Salmonella Shewenella Shigella Yersinia Vibrio
Family E E E P P E E S E E V
Hi09070800 Y Y Y Y
Vc25052592 Y Y Y Y Y Y Y
Vc25060290 YY Y
Yp58100052 Y Y Y Y Y Y
Yp58100112 Y
Yp58100200 Y YY
Yp58100206 Y Y Y Y Y Y Y
Yp58100214 Y Y
Yp58100215 Y Y Y
Yp58100233 Y Y Y Y Y Y Y
Yp58100797 Y
Total (44) 5 5 5 1 1 2 6 1 5 11 2
E = Enterobacteriaceae, P = Pasteurellaceae, S = Shewenallaaceae, V = Vibrionaceae, Y = reporter identified in at least one species from that genera 
by BLAST analysis.BMC Microbiology 2008, 8:177 http://www.biomedcentral.com/1471-2180/8/177
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nal strength and hybridisation time could be further
improved by dynamic hybridisation using microfluid
devises, rather than the static incubation used in this
study. The bioinformatic analytical methodologies will be
assessed and improved with the next version of the ASP
array, along with an increase in the number of reporters
per gene and the number of genes covered from an ever-
expanding variety of microorganisms for which genome
sequence data is becoming available.
Analysis of C. difficile 630 hybridisations demonstrated
useful genetic information can be obtained even when
there were no specific reporters for an organism on the
ASP microarray. Two of the positive reporters were
designed from drug resistance genes present on mobile
elements Tn916 in Streptococcus agalactiae 2603 V/R and
the plasmid pRUM in E. faecium U37. These genes have
been demonstrated to confer resistance to tetracycline and
erythromycin in C. difficile 630 [19], which demonstrates
that the ASP microarray can be used to obtain potential
antimicrobial resistance information when the genome
sequence is unavailable. The third positive reporter
(Ps45781390) only had limited similarity with the C. dif-
ficile 630 chromosome, and was most likely cross-hybrid-
izing to either an integrase (weak match (25/50)) match
with an integrase or to the C. difficile 630 plasmid p630
(weak match (27/50), 1 gap). This reporter was most
likely cross-hybridising. To improve the data from the ASP
microarray for this important nosocomial pathogen, C.
difficile specific reporters will be added to the next itera-
tion of ASP microarray design.
Analysis of clinical isolates such as VRE and CA-MRSA
confirmed that the ASP microarray could provide useful
information in the identification process as well as impor-
tant genetic information, such as pathogenicity traits and
antimicrobial resistance, even when no VRE specific
reporters were on the ASP microarray. Two clinical iso-
lates of VRE were successfully distinguished through the
presence of tetracycline resistance in one strain. The tetra-
cycline reporter matched 100% to a previously described
E. faecium resistance gene although it was not stated
whether the gene was located chromosomally or on a
plasmid, however this reporter was also found in vanco-
mycin resistance genes located on two E. faecalis plasmids
(pAMα1 and pJH1). The information gained from the
hybridisation patterns obtained with these two strains
improved the potential for correct identification of VRE
from future samples, where information on strain or anti-
microbial resistance profile is unavailable.
Analysis of the clinical CA-MRSA isolates was successfully
identified as S. aureus, VPL-positive and meticillin resist-
ant. Additional information revealed putative antimicro-
bial resistances and toxins previously unknown for these
strains. Furthermore eleven genes encoding important
drug resistance determinants were identified in the clini-
cal isolate, using reporters from other species. Interest-
ingly, six of which are known to be encoded on mobile
elements suggesting horizontal gene transfer.
The genetics of the emerging pathogen S. maltophilia have
only recently begun to be deciphered. However, the ASP
microarray was able to identify seven genes, one ribos-
omal and six virulence-associated genes in a clinical iso-
late of S. maltophilia. Five out of seven reporters were
subsequently confirmed to have matches in the recently
published  S. maltophilia K279a genome sequence [17]
including the ribosomal and acriflavin resistance genes.
Sample identification was also proved successful with a
blind test was performed on Y. pseudotuberculosis strain
0:56 using only information from the ribosomal report-
ers. These reporters identified Y. pseudotuberculosis as a γ-
proteobacteria and most likely Yersinia (table 3). Addi-
tionally, the combination of ribosomal and virulence
genes as a whole correctly distinguished this as Y. pseudo-
tuberculosis (p = 8.63e-199) from Y. pestis (p = 3.44e-188).
The ability to differentiate between these close relatives,
indicates that the ASP microarray will also be able to dif-
ferentiate between pathogens and closely related non-
pathogenic species.
Inclusion of further antibiotic resistance markers will
increase the utility of the ASP microarray for predicting
the antibiotic resistance profile of unknown pathogens.
As the microarray analysis can be undertaken more rap-
idly than traditional antibiotic susceptibility assays, this
may help in guiding clinicians in their choice of therapy.
For some pathogens, prompt initiation of antibiotic ther-
apy in essential. For example, CDC guidelines in the treat-
ment of plague are that antibiotic therapy should be
initiated within 24 h of the development of symptoms.
Currently it is possible to hybridise and analyse the ASP
microarray in under 24 hours however this requires prior
pathogen isolation, growth and DNA extraction and with
the emergence of multidrug resistant strains of plague [20-
22] there is an obvious need to improve the turn around
time. Improvements to the ASP microarray, with develop-
ment of faster microarray technologies and automation
along with direct detection from clinical specimens,
would make the ASP microarray invaluable in administer-
ing appropriate antibiotic prescription.
Microarray-based technology is ideal for multiple gene
identification and, therefore suited for rapid pathogen
identification particularly antibiotic resistant strains. To
this end, Berthnet et al. have recently adapted the Affyme-
trix resequencing GeneChip technology [23] to identify
bacterial and viral species from within a complex (clini-BMC Microbiology 2008, 8:177 http://www.biomedcentral.com/1471-2180/8/177
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cal) mixture and also identify and confirm the presence of
antibiotic resistances. The advantage of resequencing is
that it can identify point mutations in specific genes,
including those responsible for antibiotic resistance.
However the ASP microarray technology is cheaper and
can identify a more comprehensive range of detectable
genes.
Finally the concept of the ASP microarray design was to
monitor the flow of genetic material between bacteria,
both as an epidemiological tool and as a rapid screen of
emerging pathogens. To achieve this the primary step is to
ensure that 'normal' bacteria can be identified, along with
expected virulence factors. This proof of principle paper
establishes that the ASP microarray can do both, and has
also provided data that some of the tested isolates contain
unexpected genetic material demonstrating gene flux.
Conclusion
This proof of principle paper has demonstrated that the
ASP microarray can be used to identify a wide variety of
bacteria. More importantly, this system can also identify
virulence-associated genes that have potentially been
acquired by horizontal gene transfer. This ranges from
information that could be relevant clinically (drug resist-
ances and toxins) to the identification of potential genes
that may be important in the emergence of virulent path-
ogens. The ASP microarray has demonstrated great poten-
tial and utility for the rapid surveillance of the gene
content of a given bacterium, which could have uses clin-
ically, in aiding diagnosis and identifying appropriate
therapeutic regimens. The use may extend beyond the
clinic, in following transfer of genes and the emergence of
pathogens by pathogenicity island acquisition, for exam-
ple, as observed by the spread of the Edinburgh-Toronto
strain of Burkholderia cepacia in cystic fibrosis patients
[24]. Additionally the ASP microarray can identify novel
genes in a strain, which can be investigated using the
reporter sequence and vectorette method. The ASP micro-
array is an adaptable tool, which will be continually mod-
ified, optimised and expanded to cover more pathogens
including viruses and further virulence determinants,
enhancing its impact and making it more generally appli-
cable for diagnostic and research purposes.
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